Ownership history in NATIXIS · 7 quarters on record
This page tracks every 13F SEC filing in which NATIXIS reported a position in agilon health inc (AGL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 173,023 | — | 0% | 0.00% | $178K | $1.03 |
| 2025 Q2 | UNCHANGED | 173,023 | — | 0% | 0.00% | $398K | $2.30 |
| 2025 Q1 | ADDED | 173,023 | +173,000 | +752173.9% | 0.00% | $741K | $4.33 |
| 2024 Q4 | REDUCED | 23 | -233,366 | -100.0% | 0.00% | $44 | $1.90 |
| 2023 Q2 | ADDED | 233,389 | +199,984 | +598.7% | 0.03% | $4.0M | $17.34 |
| 2022 Q3 | REDUCED | 33,405 | -206,705 | -86.1% | 0.00% | $812K | $23.42 |
| 2022 Q2 | INITIATED | 240,110 | — | — | 0.02% | $5.2M | $21.83 |
As of 2025 Q4 — sorted by position size